CORRESP Filing
Allarity Therapeutics, Inc.
Date: Sept. 30, 2025 · CIK: 0001860657 · Accession: 0001213900-25-093435
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290521
Letter
Re: Allarity Therapeutics, Inc.
VIA EDGAR
September 30, 2025
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-3
File No. 333-290521
Acceleration Request
Requested Date: September 30, 2025
Requested Time: 5:00 p.m., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Act "), Allarity Therapeutics, Inc. (the " Company ") hereby requests the Securities and Exchange Commission take appropriate action to cause the above-referenced registration statement (the " Registration Statement ") to become effective on September 30, 2025, at 5:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Venable LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Venable LLP, by calling William N. Haddad at (212) 503-9812 or, in his absence, Arif Soto at (212) 503-0874.
Very truly yours,
ALLARITY THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm VIA EDGAR September 30, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Allarity Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-290521 Acceleration Request Requested Date: September 30, 2025 Requested Time: 5:00 p.m., Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Act "), Allarity Therapeutics, Inc. (the " Company ") hereby requests the Securities and Exchange Commission take appropriate action to cause the above-referenced registration statement (the " Registration Statement ") to become effective on September 30, 2025, at 5:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Venable LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Venable LLP, by calling William N. Haddad at (212) 503-9812 or, in his absence, Arif Soto at (212) 503-0874. Very truly yours, ALLARITY THERAPEUTICS, INC. By: /s/ Thomas H. Jensen Name: Thomas H. Jensen Title: Chief Executive Officer cc: William N. Haddad, Venable LLP Arif Soto, Venable LLP